📰 Kyle Guse News
Kyle Guse News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Kyle Guse. Real-time updates on events, politics, business and more.
July 11, 2023
Analysts at Maxim Group have reiterated a buy rating on Atossa Therapeutics Inc (NASDAQ:ATOS) shares after the biotech recently announced an enrollment...
June 1, 2023
Atossa Therapeutics Inc (NASDAQ:ATOS) has found its new chief financial officer in veteran life sciences executive and longtime board member Greg Weaver. ...
May 15, 2023
Two Phase 2 trials investigating -endoxifen in neoadjuvant setting initiated and are enrolling patientsFull enrollment of Phase 2 KARISMA mammographic breast density study expected by end of 2023Ended... | May 15, 2023
October 24, 2022
Atossa to begin Phase 2 Study of (Z)-endoxifen in 4th Quarter...
August 18, 2022
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
June 3, 2022
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
March 23, 2022
SEATTLE, March 23, 2022 -- Atossa Therapeutics, Inc. , a clinical-stage biopharmaceutical company seeking to develop innovative medicines in oncology and infectious disease with a current focus on... | March 23, 2022
January 27, 2022
SEATTLE, Jan. 27, 2022 -- Atossa Therapeutics, Inc. , a clinical stage biopharmaceutical company seeking to develop innovative medicines in areas of significant unmet medical need in oncology and...
October 21, 2021
Global Pandemic Caused a Significant Drop In Mammograms as Clinics Remained Closed...
February 16, 2021
Atossa Therapeutics Receives $21 Million from Recent Exercises of Outstanding Warrants Atossa Therapeutics Receives $21 Million from Recent Exercises of Outstanding Warrants SEATTLE, Jan. 29, 2021 — Atossa Therapeutics, Inc. (Nasdaq:ATOS), a clinical stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need with a current focus on breast cancer and COVID-19, announced that it has received $21 million from the exercise of ou...